Real-World Analysis of Adverse Event Rates After Initiation of Ibrutinib Among Medicare Beneficiaries With Chronic Lymphocytic Leukemia
Cancer Medicine
Authors
Scott F. Huntington, Enrico de Nigris, Justin T. Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric M. Sarpong, Siyang Leng, Xiaoqin Yang, Jalpa A. Doshi